Literature DB >> 3100450

Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice.

M Owhashi, Y Nawa.   

Abstract

Eosinophil chemotactic factor (ECF) was detected in the cell-free supernatant of the culture of spleen cells obtained from Schistosoma japonicum-infected mice. ECF production by spleen cells was dependent on both the amount of soluble egg antigen (SEA) added and the number of cells in the culture. When sufficient amount of SEA was added to the culture, ECF production was detectable by 6 h after incubation, reached a plateau by 24 h and then rapidly decreased. ECF was produced by nonadherent, Thy 1.2-positive cells, indicating that it is a lymphokine. After Sephadex G-75 gel chromatography, estimated molecular weight of this ECF was 15,000-20,000 daltons. When eosinophils were preincubated with this ECF lymphokine, their chemotactic reactivity to S. japonicum egg-derived ECF was significantly enhanced, although this pretreatment caused neither the deactivation of chemotactic reactivity to homologous ECF nor the enhancement of the random migration of eosinophils. Thus, this ECF lymphokine seems to be important not only as a chemoattractant but also as an activator of eosinophilotaxis around deposited eggs in schistosomiasis japonica.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100450     DOI: 10.1159/000234284

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  2 in total

1.  Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

Authors:  R Hällgren; B Gudbjörnsson; E Larsson; K Fredens
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

2.  The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways.

Authors:  Anneliese D Recklies; Chantal White; Hua Ling
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.